Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism.
Levi
S
S
Department of Medicine, Royal Postgraduate Medical School, London.
Beardshall
K
K
Swift
I
I
Foulkes
W
W
Playford
R
R
Ghosh
P
P
Calam
J
J
D000863:Antacids / Q000627:therapeutic use; D002167:Campylobacter / Q000302:isolation & purification; D002169:Campylobacter Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D004381:Duodenal Ulcer / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D005755:Gastrins / Q000097:blood*; D005756:Gastritis / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use; D011706:Pyloric Antrum / Q000382:microbiology
D000863:Antacids; D005755:Gastrins; D009942:Organometallic Compounds; D008795:Metronidazole; C002791:bismuth tripotassium dicitrate